The Form 4 filing, an SEC report of insider stock activity, was filed on Oct. 13, 2026, one day after the trade. It lists Geller Adam as Zscaler's chief product officer.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-10-12 |
| Date of Latest Transaction | 2026-10-12 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 1,042 |
| Price | $235.95 |
| Total Transaction Value | $245,859.90 |
| Insider | |
| Ticker Symbol | ZS |
| Company | Zscaler, Inc. |
| Insider Name | Geller Adam |
| Insider Title | Chief Product Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 38,308 |
| Position Size Change | 2.65% |
| Filing | |
| Filing Date | 2026-10-13 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of ZS shares, reported under transaction code S. The sale also has a possible link to an exercise or conversion, explained below.
What was the average price of the transaction?
The reported average price was $235.95 per share.
How did this transaction affect the insider's holdings?
Geller Adam sold 1,042 shares and reported owning 38,308 shares afterward. The sale represented 2.65% of the shares held before the sale.
What's the total transaction value?
The reported total value was $245,859.90. That amount covers one sale transaction on Oct. 12, 2026.
Are there any special circumstances around this transaction?
Yes. The available information identifies a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. The filing footnotes and plan details are unavailable, so it is unclear whether the reference covers this specific sale.
A match based on equal share counts also suggests a link to an exercise or conversion. Such a step can turn a stock award or another security into shares. Details of the matching acquisition are unavailable, so the link cannot be fully checked. Equal share counts do not confirm the dates, accounts or type of shares involved. They also do not prove that the shares received were the shares sold.
For research purposes only; not investment advice.